[Hemolytic-uremic syndrome and microangiopathic hemolytic anemia].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000743:Anemia, Hemolytic / Q000188:drug therapy* / Q000209:etiology; D001241:Aspirin / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000150:complications; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy / Q000209:etiology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007239:Infections / Q000150:complications; D009369:Neoplasms / Q000150:complications; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D011696:Purpura, Thrombocytopenic / Q000150:complications; D018805:Sepsis / Q000150:complications; D013156:Splenectomy; D013300:Streptokinase / Q000627:therapeutic use; D014511:Uremia / Q000188:drug therapy* / Q000209:etiology
D000305:Adrenal Cortex Hormones; D003911:Dextrans; D004176:Dipyridamole; D006493:Heparin; D013300:Streptokinase; D001241:Aspirin
La sindrome emolitico-uremica e la anemia emolitica microangiopatica.